Rakuten Medical Establishes Illuminox(TM) Alliance Institutes to Accelerate Development of …,

NCC is currently conducting clinical trials with ASP-1929, Rakuten Medical’s first investigational drug developed on the Illuminox platform. Under the …, NCC is currently conducting clinical trials with ASP-1929, Rakuten Medical’s first investigational drug developed on the Illuminox platform. Under the …, Read More

Scroll to Top